Vascular Insights® Announces New Chief Financial Officer

Wednesday, March 28, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

LISA GRUTTADAURIA WILL JOIN THE EXECUTIVE LEADERSHIP TEAM

QUINCY, Mass., March 28, 2018 /PRNewswire/ -- Vascular Insights® announced that

Lisa Gruttadauria has been appointed Chief Financial Officer.

In her most recent positions with Vascular Insights® as Controller and Director of Finance, Lisa has been consistently judicious in her management of the Company's assets, and an ally in the execution of the Company's strategic initiatives. She has over 12 years of experience in Finance and Human Resources within the medical device industry. Prior to joining Vascular Insights® in 2013, Lisa implemented and executed accounting systems, human resource processes, and procedures for early stage medical device companies in the start-up phase. Lisa holds a Bachelor's degree from Northeastern University.

Lisa commented, "I've had the pleasure to be a part of this venture from an early stage, and proud to have helped support its sustained growth and expansion into new markets.  I am delighted to join the leadership team in this role and look forward to Vascular Insights®' continued success."

Vascular Insights®, LLC engages in the design, development, manufacturing and marketing of medical devices for the minimally invasive treatment of peripheral vascular disease. The ClariVein® device has been used in more than 100,000 patients globally with excellent published results. 

If you would like more information about this topic, please contact Morgen Carroll, Product Manager or email at mcarroll@vascularinsights.com.

Contact  Morgen Carroll, Product Manager        

Telephone  203.490.2071

Email   mcarroll@vascularinsights.com

Website www.VascularInsights.com

 

Cision View original content:http://www.prnewswire.com/news-releases/vascular-insights-announces-new-chief-financial-officer-300621141.html

SOURCE Vascular Insights, LLC

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store